Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AGT103-T by Addimmune for Human Immunodeficiency Virus (HIV) Infections (AIDS): Likelihood of Approval
AGT103-T is under clinical development by Addimmune and currently in Phase I for Human Immunodeficiency Virus (HIV) Infections (AIDS). According...